InvestorsHub Logo
Followers 2
Posts 2974
Boards Moderated 0
Alias Born 06/23/2017

Re: FDApproved post# 7314

Tuesday, 10/17/2017 3:43:28 PM

Tuesday, October 17, 2017 3:43:28 PM

Post# of 44784
Again, I am not talking about the products, only the manufacturimg side. Pluristem frequently bragged about their huge advantage when it came to cogs. But it would seem that the advantage over the competition with regards to that, has in the very least diminished, if not vanished.

I have no idea if any type of cell could be grown in their bioreactor. I have always assumed so and may be wrong, I don't know. So if a competitor was going to pay someone else a large sum of money to produce their cells, why would you not want a piece of that pie. It's getting done either way, so why not. Not saying tweak their cells or help them out in any way like that. But just grow the cells and charge gobs of cash for doing so. Even a small phase 1 or 2 trial, could have brought in millions of dollars. And you would have expanded your manufacturing capability to handle anything Pluristem would need for their own use.

I don't know maybe it's just me. Seems quite logical and maybe I'm way off base. Hence the call for others to give their two cents. So far, only one usual taker.